Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples